Corporate Practice of Medicine and Fee-Splitting: Ensuring Compliance With the Prohibitions, Leveraging Exceptions
Recording of a 90-minute CLE video webinar with Q&A
This CLE course will guide healthcare counsel through the corporate practice of medicine and fee-splitting prohibitions. The panel will examine how different states address the challenges presented by the prohibitions. The panel will also offer best practices for navigating the prohibitions to ensure compliance.
- Corporate practice of medicine
- Legislation, judicial decisions, AG opinions
- Differences with kickbacks, Stark violations
- Best practices to ensure compliance
The panel will review these and other key issues:
- What limitations do the corporate practice of medicine and fee-splitting laws place on healthcare transactions?
- What is the difference between fee-splitting, a kickback, and violations of physician self-referral laws?
- What are best practices for counsel to ensure compliance with corporate practice of medicine prohibitions when structuring healthcare agreements?
Chair, Healthcare Practice Group; Co-Chair, Healthcare Private Equity Team
Bass Berry & Sims
Ms. Humphreys leads the firm’s national healthcare practice. With more than 20 years of experience, she has... | Read More
Ms. Humphreys leads the firm’s national healthcare practice. With more than 20 years of experience, she has counseled national healthcare organizations on hundreds of transactions in the healthcare industry, including hospitals and health systems, health plans, surgery centers, physician practice management companies, laboratories and healthcare information technology companies, among others. She also leads interdisciplinary teams to provide clients with creative solutions to the operational and regulatory issues they face while working within an ever-changing, complex regulatory environment.Close
Ari J. Markenson
Mr. Markenson practices at the intersection of healthcare, law, and business. He advises healthcare industry clients,... | Read More
Mr. Markenson practices at the intersection of healthcare, law, and business. He advises healthcare industry clients, including investors, lenders, providers, and suppliers, on a broad range of regulatory and corporate matters, and has significant experience conducting due diligence in complex healthcare industry acquisitions and financial transactions. He regularly represents private equity firms and lenders in such transactions and evaluates and advises on compliance and regulatory issues with regard to sellers and potential borrowers from banks and financing sources. He also advises various healthcare entities on regulatory matters, including conditions for participation, fraud and abuse, and survey, certification, licensure, and enforcement issues, Medicare and Medicaid conditions for participation, obtaining a certificate of need approval, and state licensure.Close